These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1504038)
1. The contribution of halogen atoms to protein-ligand interactions. Ippolito JA; Christianson DW Int J Biol Macromol; 1992 Aug; 14(4):193-7. PubMed ID: 1504038 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography. Kim H; Lipscomb WN Biochemistry; 1991 Aug; 30(33):8171-80. PubMed ID: 1868092 [TBL] [Abstract][Full Text] [Related]
3. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A. Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361 [TBL] [Abstract][Full Text] [Related]
4. Binding of D-phenylalanine and D-tyrosine to carboxypeptidase A. Christianson DW; Mangani S; Shoham G; Lipscomb WN J Biol Chem; 1989 Aug; 264(22):12849-53. PubMed ID: 2568989 [TBL] [Abstract][Full Text] [Related]
5. A kinetic study into the hydrolysis of the ochratoxins and analogues by carboxypeptidase A. Stander MA; Steyn PS; van Der Westhuizen FH; Payne BE Chem Res Toxicol; 2001 Mar; 14(3):302-4. PubMed ID: 11258979 [TBL] [Abstract][Full Text] [Related]
6. Interaction mode of the phe-phenyl group of thrombin receptor-tethered ligand SFLLRNP in receptor activation. Nose T; Fujita T; Nakajima M; Inoue Y; Costa T; Shimohigashi Y J Biochem; 1998 Aug; 124(2):354-8. PubMed ID: 9685726 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of carboxypeptidase A complexed with an inactivator in two crystal forms. Chai JJ; He C; Li M; Tang L; Luo M Protein Eng; 1998 Oct; 11(10):841-5. PubMed ID: 9862201 [TBL] [Abstract][Full Text] [Related]
8. X-ray diffraction study of the interaction between carboxypeptidase A and (S)-(+)-1-amino-2-phenylethyl phosphonic acid. Mangani S; Carloni P; Orioli P Eur J Biochem; 1992 Jan; 203(1-2):173-7. PubMed ID: 1730223 [TBL] [Abstract][Full Text] [Related]
9. Complex between carboxypeptidase A and a hydrated ketomethylene substrate analogue. Shoham G; Christianson DW; Oren DA Proc Natl Acad Sci U S A; 1988 Feb; 85(3):684-8. PubMed ID: 3422451 [TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis. Gardell SJ; Craik CS; Hilvert D; Urdea MS; Rutter WJ Nature; 1985 Oct 10-16; 317(6037):551-5. PubMed ID: 3840231 [TBL] [Abstract][Full Text] [Related]
11. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. Lu Y; Wang Y; Zhu W Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531 [TBL] [Abstract][Full Text] [Related]
12. Halogen-substituted phenylalanines as enantioselective selectors for enantioselective discrimination of amino acids: effect of halogen. Kumari S; Prabhakar S; Vairamani M Rapid Commun Mass Spectrom; 2008 May; 22(9):1393-8. PubMed ID: 18384196 [TBL] [Abstract][Full Text] [Related]
13. Effects of pH on the structure and function of carboxypeptidase A: crystallographic studies. Shoham G; Rees DC; Lipscomb WN Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7767-71. PubMed ID: 6595659 [TBL] [Abstract][Full Text] [Related]
14. The unusual behavior of the inhibitor S(+)(1-amino-2-phenylethyl)phosphonic acid towards carboxypeptidase A. Bal W; Bertini I; Kozlowski H; Monnanni R; Scozzafava A; Siatecki GZ J Inorg Biochem; 1990 Nov; 40(3):227-35. PubMed ID: 2292683 [TBL] [Abstract][Full Text] [Related]
15. Structure of binary and ternary complexes of zinc and cobalt carboxypeptidase A as determined by X-ray absorption fine structure. Zhang K; Auld DS Biochemistry; 1995 Dec; 34(50):16306-12. PubMed ID: 8845355 [TBL] [Abstract][Full Text] [Related]